US Stock MarketDetailed Quotes

HOWL Werewolf Therapeutics

Watchlist
  • 2.215
  • +0.055+2.55%
Trading Sep 13 09:35 ET
96.80MMarket Cap-1605P/E (TTM)

Werewolf Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
-85.86%1.14M
-83.38%742K
21.60%19.94M
-79.39%1.5M
18.65%5.9M
94.82%8.08M
4.46M
16.4M
7.28M
4.97M
Operating revenue
-85.86%1.14M
-83.38%742K
21.60%19.94M
-79.39%1.5M
18.65%5.9M
94.82%8.08M
--4.46M
--16.4M
--7.28M
--4.97M
Cost of revenue
Gross profit
Operating expense
42.09%20.1M
7.29%17.9M
-16.58%60.45M
-29.32%14.46M
-13.48%15.15M
-26.00%14.15M
8.60%16.69M
44.66%72.46M
14.42%20.46M
26.92%17.51M
Selling and administrative expenses
5.85%4.83M
0.30%5M
-0.14%18.67M
4.58%4.81M
-2.91%4.31M
-12.77%4.57M
12.67%4.98M
26.17%18.7M
2.65%4.6M
10.75%4.44M
-General and administrative expense
5.85%4.83M
0.30%5M
-0.14%18.67M
4.58%4.81M
-2.91%4.31M
-12.77%4.57M
12.67%4.98M
26.17%18.7M
2.65%4.6M
10.75%4.44M
Research and development costs
59.36%15.27M
10.27%12.91M
-22.29%41.78M
-39.16%9.65M
-17.08%10.84M
-30.99%9.58M
6.95%11.71M
52.43%53.76M
18.35%15.86M
33.54%13.07M
Operating profit
-212.51%-18.96M
-40.41%-17.16M
27.75%-40.5M
1.65%-12.96M
26.22%-9.25M
59.48%-6.07M
20.45%-12.22M
-11.92%-56.06M
26.31%-13.18M
9.10%-12.54M
Net non-operating interest income expense
-34.51%651K
-27.99%970K
124.16%4.28M
-18.15%965K
63.74%971K
924.74%994K
3,353.85%1.35M
1,734.62%1.91M
3,567.65%1.18M
998.15%593K
Non-operating interest income
-8.00%1.79M
29.89%1.97M
288.68%7.42M
248.09%4.1M
63.74%971K
1,909.28%1.95M
3,794.87%1.52M
1,734.62%1.91M
3,567.65%1.18M
998.15%593K
Non-operating interest expense
19.58%1.14M
483.14%1M
--3.14M
----
----
--955K
--172K
--0
----
----
Other net income (expense)
4,340.00%1.06M
99.91%-1K
-437.87%-1.14M
-108.57%-6K
-266.67%-5K
-108.90%-25K
-6,812.50%-1.11M
338K
70K
117.65%3K
Special income (charges)
---553K
----
----
----
----
--0
----
----
----
----
-Less:Other special charges
--553K
----
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
6,552.00%1.61M
99.91%-1K
-437.87%-1.14M
-108.57%-6K
-266.67%-5K
-108.90%-25K
-6,812.50%-1.11M
--338K
--70K
117.65%3K
Income before tax
-238.35%-17.25M
-35.14%-16.19M
30.56%-37.37M
-0.61%-12M
30.63%-8.29M
65.07%-5.1M
21.91%-11.98M
-7.66%-53.81M
33.24%-11.93M
13.19%-11.94M
Income tax
Net income
-238.35%-17.25M
-35.14%-16.19M
30.56%-37.37M
-0.61%-12M
30.63%-8.29M
65.07%-5.1M
21.91%-11.98M
-7.66%-53.81M
33.24%-11.93M
13.19%-11.94M
Net income continuous Operations
-238.35%-17.25M
-35.14%-16.19M
30.56%-37.37M
-0.61%-12M
30.63%-8.29M
65.07%-5.1M
21.91%-11.98M
-7.66%-53.81M
33.24%-11.93M
13.19%-11.94M
Minority interest income
Net income attributable to the parent company
-238.35%-17.25M
-35.14%-16.19M
30.56%-37.37M
-0.61%-12M
30.63%-8.29M
65.07%-5.1M
21.91%-11.98M
-7.66%-53.81M
33.24%-11.93M
13.19%-11.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-238.35%-17.25M
-35.14%-16.19M
30.56%-37.37M
-0.61%-12M
30.63%-8.29M
65.07%-5.1M
21.91%-11.98M
73.35%-53.81M
33.24%-11.93M
13.19%-11.94M
Basic earnings per share
-185.71%-0.4
-14.71%-0.39
43.55%-1.05
15.38%-0.33
42.50%-0.23
73.58%-0.14
39.29%-0.34
83.00%-1.86
40.91%-0.39
21.57%-0.4
Diluted earnings per share
-207.14%-0.43
-14.71%-0.39
43.55%-1.05
15.38%-0.33
42.50%-0.23
73.58%-0.14
39.29%-0.34
83.00%-1.86
40.91%-0.39
21.57%-0.4
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue -85.86%1.14M-83.38%742K21.60%19.94M-79.39%1.5M18.65%5.9M94.82%8.08M4.46M16.4M7.28M4.97M
Operating revenue -85.86%1.14M-83.38%742K21.60%19.94M-79.39%1.5M18.65%5.9M94.82%8.08M--4.46M--16.4M--7.28M--4.97M
Cost of revenue
Gross profit
Operating expense 42.09%20.1M7.29%17.9M-16.58%60.45M-29.32%14.46M-13.48%15.15M-26.00%14.15M8.60%16.69M44.66%72.46M14.42%20.46M26.92%17.51M
Selling and administrative expenses 5.85%4.83M0.30%5M-0.14%18.67M4.58%4.81M-2.91%4.31M-12.77%4.57M12.67%4.98M26.17%18.7M2.65%4.6M10.75%4.44M
-General and administrative expense 5.85%4.83M0.30%5M-0.14%18.67M4.58%4.81M-2.91%4.31M-12.77%4.57M12.67%4.98M26.17%18.7M2.65%4.6M10.75%4.44M
Research and development costs 59.36%15.27M10.27%12.91M-22.29%41.78M-39.16%9.65M-17.08%10.84M-30.99%9.58M6.95%11.71M52.43%53.76M18.35%15.86M33.54%13.07M
Operating profit -212.51%-18.96M-40.41%-17.16M27.75%-40.5M1.65%-12.96M26.22%-9.25M59.48%-6.07M20.45%-12.22M-11.92%-56.06M26.31%-13.18M9.10%-12.54M
Net non-operating interest income expense -34.51%651K-27.99%970K124.16%4.28M-18.15%965K63.74%971K924.74%994K3,353.85%1.35M1,734.62%1.91M3,567.65%1.18M998.15%593K
Non-operating interest income -8.00%1.79M29.89%1.97M288.68%7.42M248.09%4.1M63.74%971K1,909.28%1.95M3,794.87%1.52M1,734.62%1.91M3,567.65%1.18M998.15%593K
Non-operating interest expense 19.58%1.14M483.14%1M--3.14M----------955K--172K--0--------
Other net income (expense) 4,340.00%1.06M99.91%-1K-437.87%-1.14M-108.57%-6K-266.67%-5K-108.90%-25K-6,812.50%-1.11M338K70K117.65%3K
Special income (charges) ---553K------------------0----------------
-Less:Other special charges --553K------------------------------------
Other non- operating income (expenses) 6,552.00%1.61M99.91%-1K-437.87%-1.14M-108.57%-6K-266.67%-5K-108.90%-25K-6,812.50%-1.11M--338K--70K117.65%3K
Income before tax -238.35%-17.25M-35.14%-16.19M30.56%-37.37M-0.61%-12M30.63%-8.29M65.07%-5.1M21.91%-11.98M-7.66%-53.81M33.24%-11.93M13.19%-11.94M
Income tax
Net income -238.35%-17.25M-35.14%-16.19M30.56%-37.37M-0.61%-12M30.63%-8.29M65.07%-5.1M21.91%-11.98M-7.66%-53.81M33.24%-11.93M13.19%-11.94M
Net income continuous Operations -238.35%-17.25M-35.14%-16.19M30.56%-37.37M-0.61%-12M30.63%-8.29M65.07%-5.1M21.91%-11.98M-7.66%-53.81M33.24%-11.93M13.19%-11.94M
Minority interest income
Net income attributable to the parent company -238.35%-17.25M-35.14%-16.19M30.56%-37.37M-0.61%-12M30.63%-8.29M65.07%-5.1M21.91%-11.98M-7.66%-53.81M33.24%-11.93M13.19%-11.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -238.35%-17.25M-35.14%-16.19M30.56%-37.37M-0.61%-12M30.63%-8.29M65.07%-5.1M21.91%-11.98M73.35%-53.81M33.24%-11.93M13.19%-11.94M
Basic earnings per share -185.71%-0.4-14.71%-0.3943.55%-1.0515.38%-0.3342.50%-0.2373.58%-0.1439.29%-0.3483.00%-1.8640.91%-0.3921.57%-0.4
Diluted earnings per share -207.14%-0.43-14.71%-0.3943.55%-1.0515.38%-0.3342.50%-0.2373.58%-0.1439.29%-0.3483.00%-1.8640.91%-0.3921.57%-0.4
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data